NCT05411055View on ClinicalTrials.gov

Aortic Valve Neocuspidization With Glutaraldehyde-Treated Autologous Pericardium (Ozaki Procedure)

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 6, 2021

Primary Completion Date

June 6, 2026

Study Completion Date

June 6, 2027

Conditions
Aortic Valve Disease
Trial Locations (1)

48033

MCH, Cotignola

All Listed Sponsors
lead

Maria Cecilia Hospital

OTHER